Generic agrochemical manufacturer UPL has completed its acquisition of Arysta LifeScience which creates a “new UPL” with combined earnings of some $1 billion on revenues of $5 billion. The Indian multinational agreed to buy US-based Arysta from Platform Specialty...

read more